MIRA says Ketamir-2 outperforms FDA-approved neuropathic …
1 day ago — Oct. 21, 2024, 05:50 AM. MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved treatments Gabapentin and ...
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current …
18 hours ago — MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved treatments Gabapentin (Neurontin) and Pregabalin (Lyrica).Ketamir-2, a non-opioid, offers tremendous promise for ...
MIRA Continues to Post Outstanding Test Results - Yahoo Finance
1 day ago — MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment ...
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current …
1 day ago — MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders.
MIRA Pharmaceuticals, Inc. (MIRA) Latest Stock News
Get the latest MIRA Pharmaceuticals, Inc. (MIRA) stock news and headlines to help you in your trading and investing decisions.
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, News, Quote
Find the latest MIRA Pharmaceuticals, Inc. (MIRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
MIRA Pharmaceuticals Shares More Than Quadruple on Favorable …
Jul 22, 2024 — MIRA Pharmaceuticals shares rose significantly as the company reported favorable preclinical results for its oral ketamine analog.
Mira Pharmaceuticals Inc (MIRA) Stock Price & News - Google
Get the latest Mira Pharmaceuticals Inc (MIRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 …
Jul 22, 2024 — MIRA-55, if approved by the FDA, could mark a significant advancement in addressing various neuropsychiatric, inflammatory, and neurologic diseases and disorders.
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, Quote & News
5 days ago — Get a real-time MIRA Pharmaceuticals, Inc. (MIRA) stock price quote with breaking news, financials, statistics, charts and more.